Crowe, Susanne

Empagliflozin reduces body weight and indices of adipose distribution in patients with type 2 diabetes mellitus

Neeland, I. J., McGuire, D. K., Chilton, R., Crowe, S., Lund, S. S., Woerle, H. J., Broedl, U. C., & Johansen, O. E. (2016) · Diabetes and Vascular Disease Research

Diabetes Treatment and ManagementPharmacology and Obesity Treatment

Cited by 168

Empagliflozin in combination with oral agents in young and overweight/obese Type 2 diabetes mellitus patients: A pooled analysis of three randomized trials

Romera, I., Gomis, R., Crowe, S., de Pablos-Velasco, P., Aranda, U., García, A., Kis, S. G., & Naderali, E. (2016) · Journal of Diabetes and its Complications

Diabetes Treatment and ManagementPharmacology and Obesity Treatment

Cited by 9